Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin

  1. Escobar, C.
  2. Pascual-Figal, D.
  3. Manzano, L.
  4. Nuñez, J.
  5. Camafort, M.
Revue:
Journal of Clinical Medicine

ISSN: 2077-0383

Année de publication: 2023

Volumen: 12

Número: 21

Type: Révision

DOI: 10.3390/JCM12216798 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable